It is a well-known fact that with aging and mental health issues comes a loss of memory. However, so far little has been done to target this issue.
Now, researchers at Toronto's Centre for Addiction and Mental Health (CAMH) have developed novel therapeutic molecules that show promise not only in reversing the memory loss linked to these issues but also in renewing the underlying brain impairments.
"Currently there are no medications to treat cognitive symptoms such as memory loss that occur in depression, other mental illnesses, and aging," said Dr. Etienne Sibille, Deputy Director of the Campbell Family Mental Health Research Institute at CAMH and lead scientist on the study.
The development was not easy to achieve. In fact, it took several studies and stages to deliver these therapeutic molecules.
To read more, click here.